Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
King, Madeleine T.
1126  Ergebnisse:
Personensuche X
?
1

Hidden in plain sight – Survival consequences of baseline s..:

Roncolato, Felicia ; King, Madeleine T. ; O'Connell, Rachel L....
Gynecologic Oncology.  185 (2024)  - p. 128-137 , 2024
Link: https://doi.org/10.1016/..
 
?
2

External validation and diagnostic value of the Elderly Fun..:

Jespersen, Eva ; Soo, Wee Kheng ; Minet, Lisbeth R....
Journal of Geriatric Oncology.  15 (2024)  1 - p. 101675 , 2024
Link: https://doi.org/10.1016/..
 
?
3

A Hard Truth to Swallow: Critically Evaluating the MD Ander..:

McDowell, Lachlan ; King, Madeleine T. ; Hutcheson, Katherine A....
International Journal of Radiation Oncology*Biology*Physics.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Health-related quality of life and quality-adjusted progres..:

Nielsen, Lene Kongsgaard ; Schjesvold, Fredrik ; Möller, Sören...
Journal of Patient-Reported Outcomes.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

Chinese utility weights for the EORTC cancer-specific utili..:

Cao, Yiyin ; Xu, Juan ; Norman, Richard...
Quality of Life Research.  , 2024
Link: https://doi.org/10.1007/..
 
?
6

Relationship between reasons for intermittent missing patie..:

Nielsen, Lene Kongsgaard ; Mercieca-Bebber, Rebecca ; Möller, Sören...
Quality of Life Research.  33 (2024)  9 - p. 2387-2400 , 2024
Link: https://doi.org/10.1007/..
 
?
7

Danish value sets for the EORTC QLU-C10D utility instrument:

Lehmann, Jens ; Rojas-Concha, Leslye ; Petersen, Morten Aagaard...
Quality of Life Research.  33 (2024)  3 - p. 831-841 , 2024
Link: https://doi.org/10.1007/..
 
?
8

The EORTC QLU-C10D is a valid cancer-specific preference-ba..:

Pilz, Micha J. ; Seyringer, Simon ; Hallsson, Lára R....
The European Journal of Health Economics.  , 2024
Link: https://doi.org/10.1007/..
 
?
9

Cancer-Specific Health Utilities: Evaluation of Core Measur..:

Pilz, Micha J. ; Seyringer, Simone ; Al-Naesan, Imad...
PharmacoEconomics - Open.  8 (2024)  4 - p. 627-640 , 2024
Link: https://doi.org/10.1007/..
 
?
10

The EORTC QLU-C10D: the Hong Kong valuation study:

Xu, Richard Huan ; Wong, Eliza Lai-yi ; Luo, Nan...
The European Journal of Health Economics.  25 (2023)  5 - p. 889-901 , 2023
Link: https://doi.org/10.1007/..
 
?
11

An extension minimal important difference credibility item ..:

Wang, Yuting ; Devji, Tahira ; Carrasco-Labra, Alonso...
Journal of Clinical Epidemiology.  157 (2023)  - p. 46-52 , 2023
Link: https://doi.org/10.1016/..
 
?
12

United States Value Set for the Functional Assessment of Ca..:

King, Madeleine T. ; Revicki, D. A. ; Norman, R....
PharmacoEconomics - Open.  8 (2023)  1 - p. 49-63 , 2023
Link: https://doi.org/10.1007/..
 
?
13

The Psychology of COVID-19 Booster Hesitancy, Acceptance an..:

Kleitman, Sabina ; Fullerton, Dayna J. ; Law, Marvin K. H....
Vaccines.  11 (2023)  5 - p. 907 , 2023
Link: https://doi.org/10.3390/..
 
?
14

Minimally important differences for interpreting EORTC QLQ-..:

Musoro, Jammbe Z. ; Coens, Corneel ; Sprangers, Mirjam A.G....
European Journal of Cancer.  188 (2023)  - p. 171-182 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Patient-Reported Outcomes in Ovarian Cancer: Facilitating a..:

Campbell, Rachel ; King, Madeleine T ; Stockler, Martin R...
Patient Related Outcome Measures.  14 (2023)  - p. 111-126 , 2023
Link: https://doi.org/10.2147/..
 
1-15